Cambridge, Mass.
Transkaryotic Therapies Inc., based in Cambridge, is examining sites in the city to build a 200,000-sf lab and office complex, in spite of an 18-month Cambridge building moratorium currently in effect.
The leader in facility planning and space strategy conferences
